Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.12530/41677
Title: | Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation. | |
Authors: | ||
Keywords: | ||
Mesh: | ||
Issue Date: | Apr-2017 | |
Citation: | J. Allergy Clin. Immunol..2017 Apr;(139)4:1282-1292 | |
Abstract: | X-linked hyper-IgM syndrome (XHIGM) is a primary immunodeficiency with high morbidity and mortality compared with those seen in healthy subjects. Hematopoietic cell transplantation (HCT) has been considered a curative therapy, but the procedure has inherent complications and might not be available for all patients. | |
PMID: | 27697500 | |
URI: | https://hdl.handle.net/20.500.12530/41677 | |
Rights: | openAccess | |
Appears in Collections: | Fundaciones e Institutos de Investigación > IIS H. U. 12 de Octubre > Artículos | |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
PMC5374029.pdf | 719.86 kB | Adobe PDF | ![]() View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.